BioVariance Blog

Investment in high precision diagnostics

We invested in a Liquid-Chromatography coupled Tandem Mass Spectrometer (LC-MS/MS) of the newest generation. This instrument allows robust quantification of even the tiniest amounts of clinically relevant biomarkers in a wide range of biological matrices.

Success at TOP 100: Ranga Yogeshwar honors BioVariance

Ranga Yogeshwar congratulated BioVariance GmbH from Waldsassen on its success in the TOP 100 innovation competition with a personal video on 26.11.2021. In addition, the science journalist recognized the achievements of this year’s TOP 100

BioVariance gains TOP 100 award

Waldsassen, 10.02.2021 BioVariance GmbH from Waldsassen gained the TOP 100 award 2021, which is given to highly innovative medium-sized companies once a year – now for the 28th time. Before, BioVariance proved its innovative power in

New Categorization of a Cancer Indication

The Goal – Advance Personalized Medicine BioVariance GmbH focuses together with a global player from the pharmaceutical industry on advancing research in personalized medicine. Due to the outstanding cooperation and the excellent expertise of both

Effective Data Processing with BioCore Studio

Due to the rapid development of bioanalytical high-throughput technologies, such as NGS or HPLC/UPLC-MS, it became easy to generate complex data in record time. To answer research questions adequately, it is of utmost importance to